Core Points - BioMarin Pharmaceutical Inc. will present at the Jefferies Global Healthcare Conference on November 18, 2025, at 10:30 AM GMT in London, England [1] - An audio webcast of the presentation will be available live and archived on the company's website [2] - BioMarin is a global biotechnology company focused on developing medicines for rare genetic conditions, with a strong pipeline and eight commercial therapies [2] Financial Results - BioMarin announced its financial results for the third quarter ended September 30, 2025, indicating positive performance [5]